Skip to main content Help with accessibility Skip to main navigation

FOSTAMATINIB tablets (Tavlesse®▼) forthe treatment of chronic immune thrombocytopenia (ITP)

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 24 - Sep - 2020
Body System:
Grey
FOSTAMATINIB tablets (Tavlesse®▼) forthe treatment of chronic immune thrombocytopenia (ITP)

The Pan Mersey Area Prescribing Committee does not currently recommend
the prescribing of FOSTAMATINIB tablets (Tavlesse®▼) for the treatment of
chronic immune thrombocytopenia (ITP).